Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$8.18bn130.6n/a
au flag iconMSBMesoblastAU$1.90bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$808.44mn/an/a
au flag iconPYCPYC TherapeuticsAU$740.74mn/an/a
au flag iconIMMImmutepAU$349.34mn/an/a
au flag iconDXBDimerixAU$317.98mn/an/a
au flag iconCGSCogstateAU$297.42m26.67n/a
au flag iconRACRace OncologyAU$208.46mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$124.62mn/an/a
au flag iconALAArovella TherapeuticsAU$116.53mn/an/a
au flag iconIMUImugeneAU$96.71mn/an/a
au flag iconAGNArgenica TherapeuticsAU$94.79mn/an/a
au flag iconATXAmplia TherapeuticsAU$85.35mn/an/a
au flag iconBXNBioxyneAU$81.97m30.3n/a
au flag iconSNTSyntaraAU$80.53mn/an/a
au flag iconACWActinogen MedicalAU$68.92mn/an/a
au flag iconGD8GO-DX (Aust)AU$61.94mn/an/a
au flag iconLTPLtr PharmaAU$54.29mn/an/a
au flag iconATHAlterity TherapeuticsAU$53.20mn/an/a
au flag iconIDTIDT AustraliaAU$38.69mn/an/a